Production of Enantiopure Chiral Epoxides with

Dominika Gyuranová, Radka Štadániová, Zuzana Hegyi, Róbert Fischer, Martin Rebroš

Open access · goldAbstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 48% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

Recombinant Expression and Bioprocess Optimization of Priestia megaterium α-Amylase and Its Impact on Dough Fermentation Efficiency.Chemistry & biodiversity · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dominika GyuranováFaculty of Chemical and Food Technology, Institute of Biotechnology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.

Radka ŠtadániováFaculty of Chemical and Food Technology, Institute of Organic Chemistry, Catalysis and Petrochemistry, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.ORCID 0000-0003-0190-8398

Zuzana HegyiFaculty of Chemical and Food Technology, Institute of Biotechnology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.

Róbert FischerFaculty of Chemical and Food Technology, Institute of Organic Chemistry, Catalysis and Petrochemistry, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.

Martin RebrošFaculty of Chemical and Food Technology, Institute of Biotechnology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.

Slovak University of Technology in Bratislava · SK

Funding

Agentúra na Podporu Výskumu a Vývoja PP-COVID-20-0056European Regional Development Fund 313021X329Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0552/18

6 · The paper itself

Abstract

Styrene monooxygenases are a group of highly selective enzymes able to catalyse the epoxidation of alkenes to corresponding chiral epoxides in excellent enantiopurity. Chiral compounds containing oxirane ring or products of their hydrolysis represent key building blocks and precursors in organic synthesis in the pharmaceutical industry, and many of them are produced on an industrial scale. Two-component recombinant styrene monooxygenase (SMO) from

Indexed as

AlkenesBiocatalysisCatalysisEpoxy CompoundsEscherichia coliKineticsOxygenasesRecombinant ProteinsStereoisomerismStyreneSubstrate SpecificityAlkenesEpoxy CompoundsOxygenasesRecombinant ProteinsStyrenestyrene monooxygenasechiral epoxidesstyrene monooxygenasewhole-cell biocatalysis

Identifiers

PMID33802034

DOI10.3390/molecules26061514

PMCPMC8001364

OpenAlexW3134569722

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.